Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia.
Siskind D, Bull C, Suetani S, Warren N, Suraev A, McGregor I, Kisely S, De Monte V, Trott M, Shine M, Moudgil V, Robinson G, Parker S, Krishnaiah R, Stedman T, Drummond A, Medland S, Iyer R, Baker A.
Siskind D, et al. Among authors: krishnaiah r.
BJPsych Open. 2024 Oct 3;10(5):e156. doi: 10.1192/bjo.2024.748.
BJPsych Open. 2024.
PMID: 39359160
Free PMC article.